SCHEMBL5114262

SCHEMBL5114262

Cn1c(C#N)ccc1-c1ccc2c(c1)C(C)(C)CC2=NO

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PGR P06401 16/20 0.69
AR P10275 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5114259 1.00 PGR (0.69) PGRAR
SCHEMBL4430405 0.82 PGR (1.00) PGRAR
SCHEMBL5109810 0.81 PGR (0.52) PGR
SCHEMBL5109807 0.81 PGR (0.52) PGR
SCHEMBL5110100 0.77 PGR (0.67) PGRAR
SCHEMBL5110090 0.77 PGR (0.67) PGRAR
SCHEMBL5116234 0.77 PGR (0.67) PGRAR
SCHEMBL5123574 0.77 PGR (0.59) PGRAR
SCHEMBL5123571 0.77 PGR (0.59) PGRAR
SCHEMBL5109172 0.75 PGR (0.69) PGRAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414142-B2 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2008-08-19 US claimed
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2007-03-22 US claimed
US-7414142-B2 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2008-08-19 US disclosed
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators CYP19A1, PGR, GNRHR PGR 2/4885AR 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.